The healthcare system of the U.S. is well-known for its advanced structure and spending. The U.S. has the benefit of catering to leading biotechnology sector market players over other countries and hence dominating the sequencing reagents market. The US sequencing reagents market is set to trend on the historic pattern of bust and boom during the assessment period 2021-2031. The country is home to some of the biggest pharma and biotechnology companies worldwide and is set to expand its business with high returns.
U.S and Canada are one of the largest markets for sequencing reagents globally.
The countries have the highest rate of research and development among all the other countries resulting in a key region for the sequencing reagents market. Furthermore, well-established infrastructure, increasing adoption of novel sequencing technologies, and increasing healthcare expenditure are expected to fuel the sequencing reagents Market in this region.
Europe Demand Outlook for Sequencing Reagents
Europe’s biotech market attractive to investors: strong hot spots across geographies, modalities, and therapeutic areas; powerhouse research and industry expertise to support basic science and innovation; and an abundance of high-caliber talent and is likely to propel the growth of sequencing reagent market.
Cell and gene therapies (CGTs) and immunotherapies are the fastest-growing areas in the country and make Europe global powerhouse for scientific research in genomics.
Germany and UK are the most leading countries of the Europe region where spending on healthcare infrastructure is likely to be seen high. This creates opportunity for steady demand of sequencing reagent market to boost in long run.
Furthermore, it manufacturers and suppliers is to expand their business through merger and acquisitions and develop advanced technology applications for genomics.
For example, Roche signs definitive merger agreement with GenMark Diagnostics, Inc., to access novel technology to test for broad range of pathogens with one patient sample
For critical insights, request for PDF Brochure@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13155
Who are the Key Manufacturers and Suppliers of Sequencing Reagents?
Some of the leading manufacturers and suppliers of Sequencing Reagents include
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- QIAGEN
- BGI
- Pacific Biosciences of California, Inc.
- F. Hoffmann-La Roche AG
- Oxford Nanopore Technologies
- Agilent Technologies, Inc.
- Fluidigm Corporation; ArcherDX, Inc.
- Takara Bio Inc.
- Bioline.
Key manufacturers are escalating their business through developments, collaborations and geographic expansions in emerging regions, in March 2019, Agilent Technologies introduced a new library preparation system for NGS technology called Magnis NGS Prep System which was designed to easily assay and complex multiple genes and genetic aberrations from genomic DNA.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Sequencing Reagents Market Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Get Free 20% customization on Pre-Booking: https://www.futuremarketinsights.com/checkout/13155
Key Segments of Sequencing Reagents Market
By Technology:
- Sanger Sequencing
- Next-Generation Sequencing
- Third Generation Sequencing
By Reagent:
- DNTP Reagent
- DNA Polymerase Reagent
- Ampicillin Reagent
- Buffer Solution Reagent
- NGS Reagent
- Serum Reagent Kits
By Application:
- Oncology
- Virology
- Clinical Investigation
- Forensics
- RNA Sequencing
- Metagenomics
By End-user:
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
By Region:
- North America
- US
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Europe
- Germany
- Italy
- France
- U.K.
- Spain
- Russia
- Poland
- Rest of Europe
- South Asia
- India
- Thailand
- Malaysia
- Indonesia
- Rest of South Asia
- East Asia
- China
- Japan
- South Korea
- Oceania
- Australia
- New Zealand
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of MEA